Charles P. Theuer's most recent trade in 4D Molecular Therapeutics Inc was a trade of 9,333 Common Stock done at an average price of $1.1 . Disclosure was reported to the exchange on Dec. 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| 4D Molecular Therapeutics Inc | Charles P. Theuer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.14 per share. | 12 Dec 2025 | 9,333 | 41,684 | - | 1.1 | 10,640 | Common Stock |
| 4D Molecular Therapeutics Inc | Charles P. Theuer | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 9,333 | 0 | - | - | Stock Option (Right to Buy) | |
| 4D Molecular Therapeutics Inc | Charles P. Theuer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Oncternal Therapeutics Inc | Charles P. Theuer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 2,200 | 2,200 | - | - | Stock Options | |
| 4D Molecular Therapeutics Inc | Charles P. Theuer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 22,500 | 22,500 | - | - | Stock Option (Right To Buy) | |
| TRACON Pharmaceuticals Inc | Charles P. Theuer | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2024 | 518,300 | 518,300 | - | - | Employee Stock Option (Right to Buy) | |
| TRACON Pharmaceuticals Inc | Charles P. Theuer | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.14 per share. | 12 Mar 2024 | 3,500 | 402,917 (7%) | 0% | 0.1 | 482 | Common Stock |
| TRACON Pharmaceuticals Inc | Charles P. Theuer | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.13 per share. | 12 Mar 2024 | 3,500 | 406,417 (7%) | 0% | 0.1 | 467 | Common Stock |
| Oncternal Therapeutics Inc | Charles P. Theuer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2023 | 25,000 | 25,000 | - | - | Stock Options | |
| 4D Molecular Therapeutics Inc | Charles P. Theuer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| TRACON Pharmaceuticals Inc | Charles P. Theuer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.75 per share. | 26 Apr 2023 | 47,000 | 399,417 (7%) | 0% | 0.8 | 35,250 | Common Stock |
| TRACON Pharmaceuticals Inc | Charles P. Theuer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.66 per share. | 26 Apr 2023 | 3,999 | 352,417 (6%) | 0% | 0.7 | 2,639 | Common Stock |
| TRACON Pharmaceuticals Inc | Charles P. Theuer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.52 per share. | 28 Feb 2023 | 4,800 | 344,918 (6%) | 0% | 1.5 | 7,296 | Common Stock |
| TRACON Pharmaceuticals Inc | Charles P. Theuer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.52 per share. | 28 Feb 2023 | 200 | 340,118 (6%) | 0% | 1.5 | 304 | Common Stock |
| TRACON Pharmaceuticals Inc | Charles P. Theuer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 332,000 | 332,000 | - | - | Employee Stock Option (Right to Buy) | |
| TRACON Pharmaceuticals Inc | Charles P. Theuer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.62 per share. | 18 Jan 2023 | 6,800 | 339,918 (6%) | 0% | 1.6 | 11,016 | Common Stock |
| TRACON Pharmaceuticals Inc | Charles P. Theuer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.29 per share. | 14 Dec 2022 | 23,000 | 333,118 (6%) | 0% | 1.3 | 29,755 | Common Stock |
| TRACON Pharmaceuticals Inc | Charles P. Theuer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.41 per share. | 18 Nov 2022 | 13,900 | 310,118 (5%) | 0% | 1.4 | 19,599 | Common Stock |
| TRACON Pharmaceuticals Inc | Charles P. Theuer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.52 per share. | 03 Nov 2022 | 9,200 | 296,218 (5%) | 0% | 1.5 | 13,984 | Common Stock |
| TRACON Pharmaceuticals Inc | Charles P. Theuer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.59 per share. | 02 Nov 2022 | 6,000 | 287,018 (5%) | 0% | 1.6 | 9,540 | Common Stock |
| TRACON Pharmaceuticals Inc | Charles P. Theuer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.77 per share. | 07 Oct 2022 | 5,000 | 277,518 (5%) | 0% | 1.8 | 8,850 | Common Stock |
| TRACON Pharmaceuticals Inc | Charles P. Theuer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.67 per share. | 03 Oct 2022 | 5,000 | 272,518 (5%) | 0% | 1.7 | 8,350 | Common Stock |
| TRACON Pharmaceuticals Inc | Charles P. Theuer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.76 per share. | 22 Sep 2022 | 5,000 | 267,518 (4%) | 0% | 1.8 | 8,800 | Common Stock |
| TRACON Pharmaceuticals Inc | Charles P. Theuer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.85 per share. | 22 Jul 2022 | 4,500 | 262,518 (4%) | 0% | 1.9 | 8,325 | Common Stock |
| TRACON Pharmaceuticals Inc | Charles P. Theuer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.87 per share. | 12 Jul 2022 | 3,000 | 255,018 (4%) | 0% | 1.9 | 5,610 | Common Stock |
| TRACON Pharmaceuticals Inc | Charles P. Theuer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.84 per share. | 12 Jul 2022 | 3,000 | 258,018 (4%) | 0% | 1.8 | 5,520 | Common Stock |
| Oncternal Therapeutics Inc | Charles P. Theuer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 25,000 | 25,000 | - | - | Stock Options | |
| 4D Molecular Therapeutics Inc | Charles P. Theuer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2022 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| TRACON Pharmaceuticals Inc | Charles P. Theuer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.85 per share. | 09 May 2022 | 10,000 | 252,018 (4%) | 0% | 1.9 | 18,500 | Common Stock |
| TRACON Pharmaceuticals Inc | Charles P. Theuer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.97 per share. | 06 May 2022 | 2,500 | 242,018 (4%) | 0% | 2.0 | 4,925 | Common Stock |
| TRACON Pharmaceuticals Inc | Charles P. Theuer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.97 per share. | 29 Apr 2022 | 5,000 | 239,518 (4%) | 0% | 2.0 | 9,855 | Common Stock |
| TRACON Pharmaceuticals Inc | Charles P. Theuer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.30 per share. | 21 Apr 2022 | 4,500 | 234,518 (4%) | 0% | 2.3 | 10,350 | Common Stock |
| TRACON Pharmaceuticals Inc | Charles P. Theuer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.50 per share. | 08 Apr 2022 | 2,000 | 226,518 (4%) | 0% | 2.5 | 5,000 | Common Stock |
| TRACON Pharmaceuticals Inc | Charles P. Theuer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.70 per share. | 30 Mar 2022 | 4,000 | 224,518 (4%) | 0% | 2.7 | 10,800 | Common Stock |
| TRACON Pharmaceuticals Inc | Charles P. Theuer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.45 per share. | 21 Mar 2022 | 1,200 | 220,518 (4%) | 0% | 2.5 | 2,940 | Common Stock |
| TRACON Pharmaceuticals Inc | Charles P. Theuer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2022 | 265,000 | 265,000 | - | - | Employee Stock Option (Right to Buy) | |
| TRACON Pharmaceuticals Inc | Charles P. Theuer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.82 per share. | 18 Nov 2021 | 3,500 | 219,318 (4%) | 0% | 2.8 | 9,870 | Common Stock |
| TRACON Pharmaceuticals Inc | Charles P. Theuer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.88 per share. | 18 Nov 2021 | 681 | 215,818 (3%) | 0% | 2.9 | 1,961 | Common Stock |
| TRACON Pharmaceuticals Inc | Charles P. Theuer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 3.42 per share. | 05 Nov 2021 | 3,000 | 215,137 (3%) | 0% | 3.4 | 10,245 | Common Stock |
| TRACON Pharmaceuticals Inc | Charles P. Theuer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 3.41 per share. | 05 Nov 2021 | 1,000 | 212,137 (3%) | 0% | 3.4 | 3,410 | Common Stock |
| TRACON Pharmaceuticals Inc | Charles P. Theuer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 3.56 per share. | 16 Aug 2021 | 3,000 | 207,732 (3%) | 0% | 3.6 | 10,680 | Common Stock |
| Oncternal Therapeutics Inc | Charles P. Theuer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 25,000 | 25,000 | - | - | Stock Options | |
| 4D Molecular Therapeutics Inc | Charles P. Theuer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2021 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| TRACON Pharmaceuticals Inc | Charles P. Theuer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 180,000 | 180,000 | - | - | Employee Stock Option (Right to Buy) | |
| TRACON Pharmaceuticals Inc | Charles P. Theuer | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 8.98 per share. | 27 Jan 2021 | 11,000 | 201,232 (3%) | 0% | 9.0 | 98,771 | Common Stock |